Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BCSF
BCSF logo

BCSF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bain Capital Specialty Finance Inc (BCSF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.810
1 Day change
-1.00%
52 Week Range
16.000
Analysis Updated At
2026/05/01
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

BCSF is not a strong buy right now for a Beginner investor with a long-term focus and $50,000-$100,000 to invest. The stock has improving quarterly fundamentals and a supportive technical setup, but analyst targets have been cut, hedge funds are selling, and there is no strong proprietary buy signal. My direct view: hold and wait for a better confirmation, rather than buying aggressively at this level.

Technical Analysis

BCSF is in a short-term upward phase but not a clean breakout. Price closed at 13.74, above the pivot of 13.377 and near resistance at 13.652 to 13.822. MACD histogram is positive and expanding, which supports near-term momentum. However, RSI_6 at 76.495 is elevated, suggesting the move is already extended, and moving averages are converging rather than showing a strong trend acceleration. The pattern-based outlook is mixed, with a small expected near-term gain but weakness over the next week.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is mildly bullish but not strong enough to drive a buy decision. The open interest put-call ratio of 0.83 leans slightly toward calls, while option volume put-call ratio of 0.0 indicates very limited active put/call trading today. Implied volatility is high at 46.99 with IV percentile at 98.01, suggesting options are priced richly. Open interest and volume are not showing a decisive sentiment shift.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
5

Positive Catalysts

  • ["Q4 2025 revenue rose 7.23% YoY.", "Net income rose 25.51% YoY.", "EPS rose 26.47% YoY.", "Gross margin remained extremely high at 98.92%.", "The stock is trading around a discounted 0.75x NAV according to Wells Fargo.", "Upcoming Q1 2026 earnings release on May 11, 2026, provides a near-term catalyst."]

Neutral/Negative Catalysts

  • ["BofA and Wells Fargo both lowered price targets recently.", "BofA reduced its target to 13 from 14.50 and kept Neutral.", "Wells Fargo cut its target to 13 from 14 and kept Equal Weight.", "Hedge funds are selling, with selling up 136.38% over the last quarter.", "No meaningful insider buying signal.", "No recent AI Stock Picker or SwingMax signal.", "RSI is elevated, making the current entry less attractive for a beginner who wants immediate action."]

Financial Performance

In Q4 2025, Bain Capital Specialty Finance showed solid growth. Revenue increased to 66.324 million, up 7.23% year over year. Net income increased to 27.784 million, up 25.51% year over year, and EPS rose to 0.43, up 26.47% year over year. Gross margin improved slightly to 98.92%. For a BDC, this is a constructive quarter and shows improving profitability heading into Q1 2026 results.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has softened recently. BofA cut its target to 13 from 14.50 and stayed Neutral. Keefe Bruyette cut its target to 15 from 16 but kept Outperform, citing a solid quarter. Wells Fargo cut its target to 13 from 14 and kept Equal Weight, noting stability but ongoing cost-structure work. Overall, Wall Street is mixed-to-cautious: the pros like the operational stability and valuation discount, while the cons focus on limited upside and execution on costs.

Wall Street analysts forecast BCSF stock price to rise
3 Analyst Rating
Wall Street analysts forecast BCSF stock price to rise
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 13.810
sliders
Low
14
Averages
14.83
High
16
Current: 13.810
sliders
Low
14
Averages
14.83
High
16
BofA
Neutral
downgrade
$13
AI Analysis
2026-03-09
Reason
BofA
Price Target
$13
AI Analysis
2026-03-09
downgrade
Neutral
Reason
BofA lowered the firm's price target on Bain Capital Specialty Finance to $13 from $14.50 and keeps a Neutral rating on the shares. The firm is adjusting forecasts for several business development companies following quarterly reports from the group.
Keefe Bruyette
Paul Johnson
Outperform
to
Outperform
downgrade
$16 -> $15
2026-03-03
Reason
Keefe Bruyette
Paul Johnson
Price Target
$16 -> $15
2026-03-03
downgrade
Outperform
to
Outperform
Reason
Keefe Bruyette analyst Paul Johnson lowered the firm's price target on Bain Capital Specialty Finance to $15 from $16 and keeps an Outperform rating on the shares. Bain Capital Specialty Finance had a "solid" quarter, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BCSF
Unlock Now

People Also Watch